Friday, June 20, 2014

AbbVie has its eyes on Shire, should you? European stocks are typically strong performers in summer, and Shire is no exception. Shares have headed higher 9 of the last 10 years in 3 month period ending August with a median return 9.60%.  See AbbVie and other drug maker's seasonality by subscribing below.





Payment Options